Pulse Biosciences (PLSE) Change in Accured Expenses (2015 - 2025)

Pulse Biosciences' Change in Accured Expenses history runs 11 years deep, the most recent figure standing at -$1.6 million for Q4 2025.

• On a quarterly basis, Change in Accured Expenses fell 150.76% year-over-year to -$1.6 million in Q4 2025; TTM through Dec 2025 was -$3.4 million, a 207.41% decrease from a year earlier, with the FY2025 full-year figure at -$3.4 million, down 207.41% from the prior year.
• Change in Accured Expenses declined to -$1.6 million in Q4 2025 per PLSE's latest filing, from $427000.0 in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $3.2 million in Q4 2024 and bottomed at -$3.0 million in Q1 2025.
• The 5-year median for Change in Accured Expenses is $314500.0 (2021), against an average of -$8611.1.
• Across the five-year window, Change in Accured Expenses surged 49500.0% in 2023 and sank 411.69% in 2024, its largest moves.
• Year by year, Change in Accured Expenses stood at $636000.0 in 2021, then tumbled by 382.23% to -$1.8 million in 2022, then jumped by 145.13% to $810000.0 in 2023, then surged by 295.68% to $3.2 million in 2024, then plunged by 150.76% to -$1.6 million in 2025.
• Per Business Quant, the three latest PLSE Change in Accured Expenses figures stand at -$1.6 million (Q4 2025), $427000.0 (Q3 2025), and $793000.0 (Q2 2025).